PD-1 blockade enhances cytokine-induced killer cell-mediated cytotoxicity in B-cell non-Hodgkin lymphoma cell lines

The clinical utility of immune checkpoint inhibitors, such as programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors used alone or in combination with other therapies, is currently gaining attention. In this particular scenario, the inclusion of cytokine-induced kill...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology letters 2021-08, Vol.22 (2), p.1, Article 613
Hauptverfasser:	Li, Yutao, Sharma, Amit, Bloemendal, Maurits, Schmidt-Wolf, Roland, Kornek, Miroslaw, Schmidt-Wolf, Ingo
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Antibodies Apoptosis Cancer Care and treatment Cell death Clinical trials Computer software industry Cytokines Cytotoxicity Ethylenediaminetetraacetic acid Health aspects Killer cells Leukemia Life Sciences & Biomedicine Ligands Lymphoma Monoclonal antibodies Non-Hodgkin's lymphomas Oncology Penicillin Science & Technology Statistical analysis Viral antibodies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!